To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 13 Sponsors

Version Compare versions →

Referred in Senate Jul 21, 2026 · 738 words Open full page ↗

IIB

119TH CONGRESS

2D SESSION

H. R. 3029

IN THE SENATE OF THE UNITED STATES

JULY 21, 2026

Received; read twice and referred to the Committee on Commerce, Science,

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from US's completed sessions
Momentum +3 62/100 from the pace of recorded action
Time since last action -22 536 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.